Daiichi Life Insurance Co. Ltd. Takes $17.15 Million Position in CVS Health Corporation $CVS

Daiichi Life Insurance Co. Ltd. bought a new position in CVS Health Corporation (NYSE:CVS - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 165,796 shares of the pharmacy operator's stock, valued at approximately $17,152,000.

A number of other hedge funds also recently bought and sold shares of the business. Kilter Group LLC purchased a new stake in CVS Health in the 2nd quarter worth approximately $27,000. Beaird Harris Wealth Management LLC increased its stake in shares of CVS Health by 201.0% during the second quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator's stock valued at $30,000 after buying an additional 195 shares during the period. J.Safra Asset Management Corp bought a new position in shares of CVS Health during the second quarter valued at approximately $30,000. Dunhill Financial LLC purchased a new stake in CVS Health in the second quarter worth $32,000. Finally, Swiss RE Ltd. purchased a new stake in CVS Health in the fourth quarter worth $26,000. Hedge funds and other institutional investors own 80.66% of the company's stock.

CVS Health Stock Performance

Shares of CVS Health stock opened at $93.01 on Friday. CVS Health Corporation has a 12 month low of $69.51 and a 12 month high of $110.68. The firm has a market capitalization of $118.96 billion, a P/E ratio of 24.61, a P/E/G ratio of 0.85 and a beta of 0.61. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.74. The business has a fifty day simple moving average of $102.02 and a two-hundred day simple moving average of $88.86.

CVS Health (NYSE:CVS - Get Free Report) last released its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, topping analysts' consensus estimates of $1.87 by $0.71. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The firm had revenue of $106.10 billion for the quarter, compared to the consensus estimate of $100.03 billion. During the same period in the prior year, the firm earned $1.81 EPS. The company's revenue was up 7.3% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, equities analysts forecast that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd were paid a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, July 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.9%. CVS Health's dividend payout ratio (DPR) is currently 70.37%.

Wall Street Analysts Forecast Growth

CVS has been the topic of a number of research analyst reports. Wells Fargo & Company boosted their price objective on shares of CVS Health from $103.00 to $123.00 and gave the company an "overweight" rating in a research report on Monday, July 13th. Morgan Stanley lifted their target price on shares of CVS Health from $106.00 to $111.00 and gave the company an "overweight" rating in a research note on Thursday, June 4th. DA Davidson boosted their price target on shares of CVS Health from $80.00 to $100.00 and gave the company a "buy" rating in a research report on Thursday, May 7th. Robert W. Baird set a $107.00 price objective on shares of CVS Health in a report on Thursday, August 6th. Finally, JPMorgan Chase & Co. lifted their price objective on CVS Health from $111.00 to $118.00 and gave the company an "overweight" rating in a research report on Wednesday, August 12th. Twenty-two research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, CVS Health has an average rating of "Moderate Buy" and a consensus target price of $107.17.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source